SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
+0.87%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$213M
AUM Growth
+$213M
(+27%)
Cap. Flow
+$38.9M
Cap. Flow
% of AUM
18.3%
Top 10 Holdings %
Top 10 Hldgs %
45.19%
Holding
183
New
52
Increased
11
Reduced
18
Closed
46
Top Buys
| 1 |
Tenax Therapeutics
TENX
|
$11.8M |
| 2 |
BPTH
Bio-Path Holdings Inc
BPTH
|
$8.78M |
| 3 |
Opko Health
OPK
|
$7.75M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
$6.23M |
| 5 |
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
|
$6.02M |
Top Sells
| 1 |
MannKind Corp
MNKD
|
$20.5M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$5.37M |
| 3 |
MDVN
MEDIVATION, INC.
MDVN
|
$4.79M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
$4.6M |
| 5 |
Arbutus Biopharma
ABUS
|
$4.14M |
Sector Composition
| 1 | Healthcare | 87.73% |
| 2 | Energy | 1.29% |
| 3 | Communication Services | 0% |
| 4 | Materials | 0% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
STAAR Surgical
STAA
$1.35B
| – | – |
0
| – | – |
|
177
TG Therapeutics
TGTX
$5.03B
| – | – |
-66,000
| Closed | -$257K |
|
178
United Therapeutics
UTHR
$17.7B
| – | – |
0
| – | – |
|
179
Vanda Pharmaceuticals
VNDA
$279M
| – | – |
-146,350
| Closed | -$1.82M |
|
180
Vertex Pharmaceuticals
VRTX
$102B
| – | – |
0
| – | – |
|
181
SPDR NYSE Technology ETF
XNTK
$1.24B
| – | – |
0
| – | – |
|
|
VIRX
182
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| – | – |
-111,847
| Closed | -$530K |
|